Breelyn Wilky, MD, explains when patients with gastrointestinal stromal tumor should be referred for clinical trials.

The case of generic imatinib demonstrates several potential barriers to effective generic price competition for specialty prescription drugs, including fewer market entrants, smaller-than-expected ...

"Imcranib 100", the first targeted cancer drug in tablet form developed and produced in Thailand, is the result of the research and development work of Her Royal Highness Princess Chulabhorn ...

Delhi has long stood as a beacon of modern healthcare. The national capital is home to gleaming hospitals, internationally ...

Just before President Trump pushed her out at the behest of his corporate donors, former Federal Trade Commission chairwoman Lina Khan released a damning report about the most rapacious and ...

Thailand has produced its first locally developed targeted therapy pill for cancer treatment. Imcranib 100 is the result of ...

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug ...

Aussies could be left hundreds of dollars out-of-pocket as Donald Trump threatens 200 per cent tariffs on Australian ...

New domestically manufactured targeted cancer therapies, 'HERDARA' and 'IMCRANIB 100', are set to revolutionise patient ...

Cogent Biosciences, Inc. is a Strong Buy after trial data for bezuclastinib & market growth potential in systemic ...

DelveInsight's, “Gastrointestinal Stromal Tumors Pipeline Insight 2025” report provides comprehensive insights about 25+ ...

Thailand has introduced its first domestically created targeted therapy pill for cancer treatment, named Imcranib 100.